Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
TERMINATED
Total Enrollment
383 participants
Study Classification
OBSERVATIONAL
Study Start Date
2013-08-31
Study Completion Date
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To show that having less qualified personnel (non-Laboratory trained professionals) perform the test yields the same result as if a Laboratory trained professional performed the test.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Value of Amniopatch in Preterm Premature Rupture of Membranes
NCT03473210
Preterm Premature Rupture of Membrane
COMPLETED
NA
Treatment of Classic Mid-trimester PPROM by Means of Continuous Amnioinfusion
NCT04696003
Bronchopulmonary Dysplasia
Necrotizing Enterocolitis
Intracranial Hemorrhages
UNKNOWN
PHASE3
Hospital Admission Versus Home Management in Women With Premature Rupture of Membranes :RCT
NCT03435263
Management of Women With PROM at Term
UNKNOWN
Early Versus Delayed Artificial Rupture of Membranes (AROM Trial)
NCT04496908
Induction of Labor Affected Fetus / Newborn
COMPLETED
EARLY_PHASE1
Accuracy and Reliability of Fetal Heart Rate and Uterine Contraction Monitoring Method
NCT01280357
Pregnancy; Habitual Aborter
Weeks of Gestation 37 or More
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main goal of this study is to show that when performed by less qualified personnel, the AmniSure® ROM Test is so simple and accurate that the likelihood of erroneous results by the Intended-User is negligible and that the test poses no unreasonable risk of harm to the patient if performed incorrectly.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Rupture of Fetal Membranes
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
CASE_ONLY
Study Time Perspective
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Symptomatic
Individuals with signs, symptoms or suspicion of membrane rupture at 11 to 42 weeks gestation that will receive the AmniSure ROM test.
AmniSure ROM test
Intervention Type
DEVICE
Comparison of AmniSure ROM test to clinical diagnosis of ROM.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AmniSure ROM test
Comparison of AmniSure ROM test to clinical diagnosis of ROM.
Intervention Type
DEVICE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects must be pregnant.
* Subjects must be between 18 and 50 years of age and have a gestational age of 11.0-42.0 weeks.
* Subjects reporting suspicion, signs, or symptoms suggestive of ROM, PROM, PPROM.
* Subjects providing informed consent.
* Subjects must be between 18 and 50 years of age and have a gestational age of 11.0-42.0 weeks.
* Subjects reporting suspicion, signs, or symptoms suggestive of ROM, PROM, PPROM.
* Subjects providing informed consent.
Exclusion Criteria
* Subjects who have placenta previa.
* Subjects who have heavy vaginal bleeding.
* Subjects who have had digital vaginal examination immediately prior to evaluation for ROM.
* Subjects who have heavy vaginal bleeding.
* Subjects who have had digital vaginal examination immediately prior to evaluation for ROM.
Minimum Eligible Age
18 Years
Maximum Eligible Age
50 Years
Eligible Sex
FEMALE
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
QIAGEN Gaithersburg, Inc
INDUSTRY
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Responsibility Role
SPONSOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California San Francisco- Fresno
Fresno, California, United States
Site Status
Indiana University
Indianapolis, Indiana, United States
Site Status
Kansas University Medical Center Research Institute, Inc
Kansas City, Kansas, United States
Site Status
Medical University of South Carolina
Charleston, South Carolina, United States
Site Status
Countries
Review the countries where the study has at least one active or historical site.
United States
References
Explore related publications, articles, or registry entries linked to this study.
Johnson JW, Daikoku NH, Niebyl JR, Johnson TR Jr, Khouzami VA, Witter FR. Premature rupture of the membranes and prolonged latency. Obstet Gynecol. 1981 May;57(5):547-56.
Reference Type
BACKGROUND
LEBHERZ TB, HELLMAN LP, MADDING R, ANCTIL A, ARJE SL. DOUBLE-BLIND STUDY OF PREMATURE RUPTURE OF THE MEMBRANES. A REPORT OF 1,896 CASES. Am J Obstet Gynecol. 1963 Sep 15;87:218-25. doi: 10.1016/0002-9378(63)90502-7. No abstract available.
Reference Type
BACKGROUND
Gunn GC, Mishell DR Jr, Morton DG. Premature rupture of the fetal membranes. A review. Am J Obstet Gynecol. 1970 Feb 1;106(3):469-83. doi: 10.1016/0002-9378(70)90378-9. No abstract available.
Reference Type
BACKGROUND
Sacks M, Baker TH. Spontaneous premature rupture of the membranes. A prospective study. Am J Obstet Gynecol. 1967 Apr 1;97(7):888-93. doi: 10.1016/0002-9378(67)90512-1. No abstract available.
Reference Type
BACKGROUND
Daikoku NH, Kaltreider DF, Khouzami VA, Spence M, Johnson JW. Premature rupture of membranes and spontaneous preterm labor: maternal endometritis risks. Obstet Gynecol. 1982 Jan;59(1):13-20.
Reference Type
BACKGROUND
Christensen KK, Christensen P, Ingemarsson I, Mardh PA, Nordenfelt E, Ripa T, Solum T, Svenningsen N. A study of complications in preterm deliveries after prolonged premature rupture of the membranes. Obstet Gynecol. 1976 Dec;48(6):670-7.
Reference Type
BACKGROUND
Fayez JA, Hasan AA, Jonas HS, Miller GL. Management of premature rupture of the membranes. Obstet Gynecol. 1978 Jul;52(1):17-21.
Reference Type
BACKGROUND
Alexander JM, Cox SM. Clinical course of premature rupture of the membranes. Semin Perinatol. 1996 Oct;20(5):369-74. doi: 10.1016/s0146-0005(96)80003-6.
Reference Type
BACKGROUND
Philipson EH, Hoffman DS, Hansen GO, Ingardia CJ. Preterm premature rupture of membranes: experience with latent periods in excess of seven days. Am J Perinatol. 1994 Nov;11(6):416-9. doi: 10.1055/s-2007-994609.
Reference Type
BACKGROUND
Lockwood CJ, Wein R, Chien D, Ghidini A, Alvarez M, Berkowitz RL. Fetal membrane rupture is associated with the presence of insulin-like growth factor-binding protein-1 in vaginal secretions. Am J Obstet Gynecol. 1994 Jul;171(1):146-50. doi: 10.1016/0002-9378(94)90461-8.
Reference Type
BACKGROUND
Fuks et al. N-Dia Amnisure Abstract.
Reference Type
BACKGROUND
ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2007 Apr;109(4):1007-19. doi: 10.1097/01.AOG.0000263888.69178.1f.
Reference Type
BACKGROUND
Nisell H, Hagskog K, Westgren M. Assessment of fetal fibronectin in cervical secretion in cases of equivocal rupture of the membranes at term. Acta Obstet Gynecol Scand. 1996 Feb;75(2):132-4. doi: 10.3109/00016349609033304.
Reference Type
BACKGROUND
Atterbury JL, Groome LJ, Hoff C. Methods used to diagnose premature rupture of membranes: a national survey of 812 obstetric nurses. Obstet Gynecol. 1998 Sep;92(3):384-9. doi: 10.1016/s0029-7844(98)00178-1.
Reference Type
BACKGROUND
de Haan HH, Offermans PM, Smits F, Schouten HJ, Peeters LL. Value of the fern test to confirm or reject the diagnosis of ruptured membranes is modest in nonlaboring women presenting with nonspecific vaginal fluid loss. Am J Perinatol. 1994 Jan;11(1):46-50. doi: 10.1055/s-2007-994535.
Reference Type
BACKGROUND
Jeurgens-Borst AJ, Bekkers RL, Sporken JM, van den Berg PP. Use of insulin like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Eur J Obstet Gynecol Reprod Biol. 2002 Apr 10;102(1):11-4. doi: 10.1016/s0301-2115(01)00560-7.
Reference Type
BACKGROUND
Watanabe T, Minakami H, Itoi H, Sato I, Sakata Y, Tamada T. Evaluation of latex agglutination test for alpha-fetoprotein in diagnosing rupture of fetal membranes. Gynecol Obstet Invest. 1995;39(1):15-8. doi: 10.1159/000292368.
Reference Type
BACKGROUND
Fujimoto S, Kishida T, Sagawa T, Negishi H, Okuyama K, Hareyama H, Makinoda S. Clinical usefulness of the dye-injection method for diagnosing premature rupture of the membranes in equivocal cases. J Obstet Gynaecol (Tokyo 1995). 1995 Jun;21(3):215-20. doi: 10.1111/j.1447-0756.1995.tb01000.x.
Reference Type
BACKGROUND
Birkenmaier A, Ries JJ, Kuhle J, Burki N, Lapaire O, Hosli I. Placental alpha-microglobulin-1 to detect uncertain rupture of membranes in a European cohort of pregnancies. Arch Gynecol Obstet. 2012 Jan;285(1):21-5. doi: 10.1007/s00404-011-1895-9. Epub 2011 Apr 8.
Reference Type
BACKGROUND
Lee SE, Park JS, Norwitz ER, Kim KW, Park HS, Jun JK. Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol. 2007 Mar;109(3):634-40. doi: 10.1097/01.AOG.0000252706.46734.0a.
Reference Type
BACKGROUND
Eriksen NL, Parisi VM, Daoust S, Flamm B, Garite TJ, Cox SM. Fetal fibronectin: a method for detecting the presence of amniotic fluid. Obstet Gynecol. 1992 Sep;80(3 Pt 1):451-4.
Reference Type
BACKGROUND
El-Messidi A, Cameron A. Diagnosis of premature rupture of membranes: inspiration from the past and insights for the future. J Obstet Gynaecol Can. 2010 Jun;32(6):561-569. doi: 10.1016/S1701-2163(16)34525-X.
Reference Type
BACKGROUND
Hellemans P, Verdonk P, Baekelandt M, Joostens M, Francx M, Gerris J. Preliminary results with the use of the ROM-check immunoassay in the early detection of rupture of the amniotic membranes. Eur J Obstet Gynecol Reprod Biol. 1992 Feb 28;43(3):173-9. doi: 10.1016/0028-2243(92)90170-4.
Reference Type
BACKGROUND
Duff P & Lockwood, C. Diagnosis of Premature Rupture of Membranes.Up-to-Date, 2011.
Reference Type
BACKGROUND
Di Renzo GC, Roura LC, Facchinetti F, Antsaklis A, Breborowicz G, Gratacos E, Husslein P, Lamont R, Mikhailov A, Montenegro N, Radunovic N, Robson M, Robson SC, Sen C, Shennan A, Stamatian F, Ville Y. Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth. J Matern Fetal Neonatal Med. 2011 May;24(5):659-67. doi: 10.3109/14767058.2011.553694. Epub 2011 Mar 2. No abstract available.
Reference Type
BACKGROUND
Sayres W. Chapter D: Preterm Labor & Premature Rupture of Membranes, AAFP-ALSO, June 2011.
Reference Type
BACKGROUND
Mercer B. Premature Rupture of the Membranes. In: Gabbe SG, Niebyl JR, Galn HL, Jauniaux EM, Landon MB, Simpson JL, Driscoll DA, eds. Obstetrics: Normal and Problem Pregnancies. 6th ed. Philadelphia, PA: Saunders-Elsevier; 2012: 663.
Reference Type
BACKGROUND
Mariona FG, Cabero L. Are we ready for a new look at the diagnosis of premature rupture of membranes? J Matern Fetal Neonatal Med. 2012 Apr;25(4):403-7. doi: 10.3109/14767058.2011.581715. Epub 2011 Jun 1.
Reference Type
BACKGROUND
Kurdoglu M, Kolusari A, Adali E, Yildizhan R, Kurdoglu Z, Kucukaydin Z, Kaya A, Kirimi E, Sahin HG, Kamaci M. Does residual amniotic fluid after preterm premature rupture of membranes have an effect on perinatal outcomes? 12 years experience of a tertiary care center. Arch Gynecol Obstet. 2010 Apr;281(4):601-7. doi: 10.1007/s00404-009-1147-4. Epub 2009 Jun 12.
Reference Type
BACKGROUND
Gungorduk K, Asicioglu O, Besimoglu B, Gungorduk OC, Yildirm G, Ark C, Sahbaz A. Labor induction in term premature rupture of membranes: comparison between oxytocin and dinoprostone followed 6 hours later by oxytocin. Am J Obstet Gynecol. 2012 Jan;206(1):60.e1-8. doi: 10.1016/j.ajog.2011.07.035. Epub 2011 Jul 30.
Reference Type
BACKGROUND
Combs CA, Garite TJ, Maurel K, Mallory K, Edwards RK, Lu G, Porreco R, Das A; Obstetrix Collaborative Research Network. 17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial. BMC Res Notes. 2011 Dec 29;4:568. doi: 10.1186/1756-0500-4-568.
Reference Type
BACKGROUND
Derbent AU, Simavli SA, Kafali H, Turhan N. A comparison of subgroups of spontaneous preterm delivery: preterm labor with intact membranes and preterm premature rupture of membranes. Anatol J Obstet Gynecol 2012; 1: 1
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C13-ROM-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Cervical Ripening in Premature Rupture of Membranes
NCT02314728
COMPLETED
NA
Amnioinfusion Initiative
NCT00787163
UNKNOWN
PHASE3
PeRinatal Outcomes With ACTive Versus Expectant Management of Women With Pre-labor Rupture Of Membranes
NCT05958953
NOT_YET_RECRUITING
PHASE3
Preterm Premature Rupture of Fetal Membranes: Cervical Ultrasound and Biological Markers to Diagnose Prematurity (RECHOBIOL)
NCT04237142
UNKNOWN
NA
Multichannel EMG Diagnosing True Preterm Labor
NCT03785795
COMPLETED
FOLCROM Trial: Foley Catheter in Rupture of Membranes
NCT01973036
COMPLETED
NA
Premature Rupture of Membranes at 34 to 37 Weeks' Gestation
NCT03689062
UNKNOWN
NA
Best Cutoff Value of Lactate Concentration in Vaginal Fluid to Predict Time of Spontaneous Onset of Labor in PPROM
NCT03463811
UNKNOWN
Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term
NCT01633294
COMPLETED
PHASE2/PHASE3
Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes
NCT02469519
COMPLETED
PHASE2/PHASE3
General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)
NCT04773314
COMPLETED
Tearing of Membranes Before Birth - a Comparison Between Two Ways of Induction of Labor Pitocin Opposite Prostaglandin
NCT02720978
UNKNOWN
PHASE3
Multi-Reader Multi-Case Study to Identify Uterine Contractions Recorded From Laboring and Nonlaboring Patients by Practicing Clinicians
NCT01730963
COMPLETED
Comparing Two Prophylactic Antibiotic Protocols in Women With Term Prolonged Pre-labor Rupture of Membrane and Preterm Labor
NCT05469984
RECRUITING
NA
Impact of Early Rupture of the Residual Membrane on Latency Before Labour Begins
NCT07301957
NOT_YET_RECRUITING
NA
Safety and Efficacy Study of Intentional Delivery in Women With Preterm and Prelabour Rupture of the Membranes
NCT00259519
TERMINATED
NA
Preterm Induction of Labor Timing of Amniotomy: A Randomized Controlled Trial
NCT03504670
COMPLETED
NA
Multi-Reader Multi-Case Study to Identify Uterine Contractions Recorded From Laboring Patients by Practicing Clinicians
NCT01282723
COMPLETED
Vaginal Fluid Wash in Pre-labour Rupture of Membranes
NCT02111148
UNKNOWN
NA
TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden
NCT07107477
RECRUITING
PHASE3
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
NCT00201656
TERMINATED
PHASE4
PROMMO Trial: Oral Misoprostol vs IV Oxytocin
NCT04478942
COMPLETED
EARLY_PHASE1
Foley vs Propess for Induction of Labor in Women With Term PROM : Mode of Delivery, Maternal and Fetal Outcomes
NCT04565340
COMPLETED
Magnesium Sulfate Versus Placebo for Tocolysis in PPROM
NCT00463736
TERMINATED
NA
Provider RCT PROMOTE
NCT07126405
WITHDRAWN
NA